Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Breast cancer is the most common malignant tumor in women and a quantitative contrast‐free method is highly desirable for its diagnosis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To investigate the performance of quantitative MRI in differentiating malignant from benign breast lesions and to compare with the Breast Imaging Reporting and Data System (BI‐RADS).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Subjects</h3><p>Eighty patients (56 with malignant lesions and 24 with benign lesions).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>Diffusion‐weighted imaging (DWI) with a single‐shot echo planar sequence and synthetic MRI with magnetic resonance image compilation (MAGiC) were performed at 3T.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>T<sub>1</sub> relaxation time (T<sub>1</sub>), T<sub>2</sub> relaxation time (T<sub>2</sub>), and proton density (PD) from synthetic MRI and apparent diffusion coefficient (ADC) from DWI were analyzed by two radiologists (Reader A, Reader B). Univariable and multivariable models were developed to optimize differentiation between malignant and benign lesions and their performances compared to BI‐RADS. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>The diagnostic performance was evaluated using multivariate logistic regression analysis and area under the receiver operating characteristic (ROC) curves (AUC).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>T<sub>2</sub>, PD, and ADC values for malignant lesions were significantly lower than those in benign breast lesions for both radiologists (all <i>P</i> < 0.05). The combined T<sub>2</sub>, PD, and ADC model had the best performance for differentiating malignant and benign lesions with AUC, sensitivity, specificity, positive predictive value, and negative predictive values of 0.904, 94.6%, 87.5%, 94.6%, and 87.5%, respectively. The corresponding results for BI‐RADS were no AUC, 94.6%, 75.0%, 89.8%, and 85.7%, respectively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>The approach that combined synthetic MRI and DWI outperformed BI‐RADS in the differential diagnosis of malignant and benign breast lesions and was achieved without contrast agents. This approach may serve as an alternative and effective strategy for the improvement of breast lesion differentiation.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>3.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>3.</p></section>

Investigation of imaging features in contrast-enhanced magnetic resonance imaging of benign and malignant breast lesions

Can Combined Screening of Ultrasound and Elastography Improve Breast Cancer Identification Compared with MRI in Women with Dense Breasts-a Multicenter Prospective Study

A New Application of Multimodality Radiomics Improves Diagnostic Accuracy of Nonpalpable Breast Lesions in Patients with Microcalcifications-Only in Mammography

Benign and Malignant Breast Lesions in Dynamic Contrast-Enhanced Magnetic Resonance Analysis

Diagnostic performance of contrast-enhanced ultrasound and enhanced magnetic resonance for breast nodules

Contrast-enhanced MR Angiography and BI-RADS for Diagnosis of Breast Cancer

Diagnosis of Suspicious Breast Lesions Using an Empirical Mathematical Model for Dynamic Contrast-Enhanced MRI

A Machine Learning-Based Unenhanced Radiomics Approach to Distinguishing Between Benign and Malignant Breast Lesions Using T2-Weighted and Diffusion-Weighted MRI.

New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing

Comparative Study of Contrast-Enhanced Ultrasound and MRI Used in Breast Intraductal Lesions

Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI

Benign breast lesions that simulate malignancy: magnetic resonance imaging with radiologic-pathologic correlation

Value of Contrast-Enhanced Microflow Imaging in Diagnosis of Breast Masses in Comparison with Contrast-Enhanced Ultrasound

Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI‐RADS

A multiparametric approach to diagnosing breast lesions using diffusion-weighted imaging and ultrafast dynamic contrast-enhanced MRI

A multicenter, randomized, controlled, single-blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast-enhanced MRI of the body regions or extremities.

Pilot study: A simple CAD-based tool to detect breast cancer on MRI of the breast

Sensitivity of Contrast-Enhanced Breast MRI vs X-ray Mammography Based on Cancer Histology, Tumor Grading, Receptor Status, and Molecular Subtype: A Supplemental Analysis of 2 Large Phase III Studies

Synthetic MRI, multiplexed sensitivity encoding, and BI-RADS for benign and malignant breast cancer discrimination

Comparison of Performance in Diagnosis and Characterization of Breast Lesions: Contrast-Enhanced Mammography vs. Breast Magnetic Resonance Imaging

Diagnostic Performance of Contrast-Enhanced Spectral Mammography